ArticleMediators of inflammation2017

AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin.

Junting Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.